or
forgot password
  • cancer clinical trials in northridge, CA

  • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Leavey Cancer Center at Northridge Hospital Medical Center
    Northridge, California 91325
    Breast Cancer
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Northridge Hospital Medical Center
    Northridge, California 91328
    Alzheimer Disease
    Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Breast Cancer
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Colorectal Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    North Valley Hem Onc Med Grp
    Northridge, California 91325
    Non-Small Cell Lung Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Northridge Hospital Medical Center
    Northridge, California 91328
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    North Valley Hematology/Oncology Providence Holy Cross Medical
    Northridge, California 91328
    Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Northridge Hospital Medical Center
    Northridge, California 91328
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Leavey Cancer Center at Northridge Hospital Medical Center
    Northridge, California 91325
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
    Location# 051
    Northridge, California 91235
    Metastatic Colorectal Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Northridge Hospital Medical Center
    Northridge, California 91328
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Esophageal Cancer, Gastric Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    TORI - North Valley Hematology/Oncology
    Northridge, California 91328
    Multiple Myeloma
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10101 Boehringer Ingelheim Investigational Site
    Northridge, California
    Breast Neoplasms
    Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
    TORI NORTHRIDGE (North Valley Hematology/Oncology Medical Group)
    Northridge, California 91325
    Acinar Cell Carcinoma of Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Pancreatic Carcinoma Recurrent, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Pancreatic Carcinoma Stage III
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    The Thomas and Dorothy Leavey Cancer Center Northridge Hospital Medical Center
    Northridge, California 91328
    Metastatic Colorectal Cancer, Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Leavey Cancer Center at Northridge Hospital Medical Center
    Northridge, California 91325
    Anal Cancer
    Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
    Northridge Hospital Medical Center
    Northridge, California 91328
    Gastric Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Leavey Cancer Center at Northridge Hospital Medical Center
    Northridge, California 91325
    Breast Cancer
    Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
    Leavey Cancer Center at Northridge Hospital Medical Center
    Northridge, California 91325
    Esophageal Cancer, Gastric Cancer
    Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Lymphoma, Non-Hodgkin
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Leavey Cancer Center at Northridge Hospital Medical Center
    Northridge, California 91325
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    Northridge Surgery & Pain Management Center
    Northridge, California 91324
    Pain
    A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
    North Valley Hematology/Oncology Medical Group (TORI)
    Northridge, California 91328
    Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    North Valley Hematology/Oncology Medical Group, The Thomas and Dorothy Leavey Cancer Center
    Northridge, California 91328
    Prostate Cancer
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Prostate Cancer
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    North Valley Hematology/Oncology Medical GroupThe Thomas and Dorothy Leavey Cancer Center
    Northridge, California 91325
    Carcinoma, Non-Small-Cell Lung
    Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
    The Thomas and Dorothy Leavey Cancer Center
    Northridge, California 91328
    Acute Myeloid Leukemia, AML
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Prostate Cancer
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    North Valley Hematology/Oncology Medical Group: The Thomas & Dorothy Leavey Cancer Center
    Northridge, California 91325
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
    North Valley Hematology/Oncology Medical
    Northridge, California 91325
    Ovarian Cancer, Endometrial Cancer
    Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Adenocarcinoma of the Lung
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Myelodysplastic Syndrome (MDS)
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Non-small Cell Lung Cancer
    Safety and Efficacy Study of Switching From Epzicom to Truvada
    Tarzana Treatment Center
    Northridge, California 91324
    HIV Infection
    A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
    North Valley Hematology/Oncology Medical Group
    Northridge, California 91328
    Non-Small Cell Lung Cancer